Intermittent Fasting and Parkinson’s Disease: A Mitochondrial Perspective
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder,
Rewiring Possibilities: How One Enzyme Could Change the Future of Parkinson’s Treatment
In a stunning advancement for neurodegenerative research, scientists at Stanford
Precision Medicine for Parkinson’s Disease
Parkinson’s disease (PD), affecting over 10 million people globally, is
New Research Offers Hope for Early Diagnosis of Parkinson’s and MSA
A groundbreaking study from the University of Auckland is offering
Professor Bastiaan Bloem
Bas Bloem, neurologist and Professor of Neurological Movement Disorders, founded